Lourdes Gombau, head of the R&D Department, and Maria Riba, Business Development Manager, presented in the UK the last scientific article of the company, shedding light on the topic of compound intestinal toxicity.
On May 15-17, the 22nd Barrier- and Transporter- days took place in Germany. At the event, Jonatan Cucala, R&D researcher at ReadyCell, presented a poster entitled “PreadyTake, an in vitro ready-to-use cell-based model to evaluate potential drug-transporter interactions.”
Last Thursday, R&D Director Lourdes Gombau presented “Women and Science”, a seminar that aimed to raise awareness of the role of women in the scientific field throughout history and at present.
ReadyCell is partaking in a new collaborative project together with Leitat Technological Center and Vall d’Hebron Institute of Research (VHIR). The project aims to develop microphysiological systems based on liver-on-chip for drug discovery and testing.
MDCKII cells based in vitro system is a recommended model to evaluate blood-brain barrier permeability during CNS action novel compounds.
